Advanced Search

Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2002 August;43(4) > The Journal of Cardiovascular Surgery 2002 August;43(4):437-40

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632

Frequency: Bi-Monthly

ISSN 0021-9509

Online ISSN 1827-191X

 

The Journal of Cardiovascular Surgery 2002 August;43(4):437-40

CARDIAC SECTION 

    ORIGINAL ARTICLES

Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass

Sugita T. 1, Watarida S. 2, Katsuyama K. 2, Nakajima Y. 2, Yamamoto R. 2, Mori A. 2

1 Depart­ment of Car­di­o­vas­cular Sur­gery, Tenri Hos­pital, ­Tenri, ­Japan
2 Second Depart­ment of Sur­gery, Shiga Uni­ver­sity of Med­ical Sci­ence, ­Otsu, ­Japan

Back­ground. We per­formed ­this pros­pec­tive ran­dom­ized ­study to deter­mine the ­effect of a ­human uri­nary pro­tease inhib­itor (Uli­nas­tatin) on res­pir­a­tory func­tion in pedi­atric ­patients under­going car­di­o­pul­mo­nary ­bypass.
­Methods. ­Twenty-two chil­dren ­were ­included in ­this ­study. ­They ­were ran­domly allo­cated to 1 of the fol­lowing ­groups; a con­trol ­group (n=11) or a Uli­nas­tatin ­group (n=11) in ­which ­patients ­received 5000 U/kg of Uli­nas­tatin. Arte­rial ­blood sam­ples ­were ­obtained ­before cardiopulmonary bypass (CPB), imme­di­ately ­after CPB, and 30 min­ ­after pro­ta­mine admin­is­tra­tion, as ­well as 3 ­hours ­after and 18 ­hours ­after CPB, and Inter­leukin-8 and neu­trophil elas­tase con­cen­tra­tion ­were eval­u­ated.
­Results. CPB ­time and ­aortic ­clamp ­time did not ­differ ­between the ­groups. Inter­leukin 8 and neu­trophil elas­tase con­cen­tra­tions ­before CPB ­increased sig­nif­i­cantly imme­di­ately ­after CPB, ­these con­cen­tra­tions did not ­differ ­between the ­groups. How­ever, neu­trophil elas­tase con­cen­tra­tions of a Uli­nas­tatin ­group ­were sig­nif­i­cantly lower ­than ­that of a con­trol ­group at 30 min after pro­ta­mine admin­is­tra­tion (a Uli­nas­tatin ­group: 1011.3±539.1 μg/ml, a con­trol ­group: 1619.7±595.7 μg/ml, p<0.05) and A-aDO2 of a Uli­nas­tatin ­group was sig­nif­i­cantly ­lower ­than ­that of a con­trol ­group at 2 ­hours ­after CPB (a Uli­nas­tatin ­group: 67.1±70.6 ­mmHg, a con­trol ­group: 169.2±116.3 g, p<0.05).
Con­clu­sions. ­These ­results sug­gest ­that Uli­nas­tatin sup­presses the ­increase in neu­trophil elas­tase and pro­tects the res­pir­a­tory func­tion in pedi­atric ­patients under­going car­di­o­pul­mo­nary ­bypass.

language: English


FULL TEXT  REPRINTS

top of page